She leads the research group “Translational research on solid tumours” at the Institute for Cancer Research, Norwegian Radium Hospital (NRH), Oslo, focusing on translational studies on solid tumours, with a special interest in lung cancers and pancreatic cancers. She furthermore leads several clinical and translational studies in lung cancer. Currently, she leads the investigator-initiated DART-trial, a translational study for patients with stage III NSCLC, the NIPU trial – a study evaluating ipi-nivo and ipi-nivo + UV1 vaccine in patients with malignant mesothelioma, and the IMPRESS-Norway study. The IMPRESS-Norway study with the goal of “Improving public cancer care by implementing precision medicine in Norway,” is a national clinical study for patients with advanced cancer after standard therapy. The study is also supported by public research funding in addition to funding for the diagnostics.